Diagonal starts up with $128M to make better 'activator' antibody drugs
BioPharma
United States United Kingdom Michael Gladstone Alex Lugovskoy Atlas Venture Merrimack Pharmaceuticals
Source: biopharmadive.com
📰 Michael Gladstone News
Michael Gladstone News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Gladstone. Real-time updates on events, politics, business and more.
Pentwater Capital Management LP - Correction: Form 8.3 - Horizon Therapeutics Plc
Pentwater Capital Management LP - Form 8.3 - Horizon Therapeutics Plc PR Newswire London, December 14 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH
United States City Of United Kingdom Michael Gladstone Panel Market Surveillance Unit Horizon Therapeutics Plc
Source: finanznachrichten.de
Pentwater Capital Management LP - Form 8.3 - Horizon Therapeutics Plc
Pentwater Capital Management LP - Form 8.3 - Horizon Therapeutics Plc PR Newswire London, December 13 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE
United States City Of United Kingdom Michael Gladstone Panel Market Surveillance Unit Horizon Therapeutics Plc
Source: finanznachrichten.de
Pentwater Capital Management LP - Form 8.3
Pentwater Capital Management LP - Form 8.3 - HomeServe plc PR Newswire London, November 23 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON
United States City Of United Kingdom Michael Gladstone Panel Market Surveillance Unit Regulatory Information Service
Source: finanznachrichten.de
Pheon Therapeutics Raises $68M in Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors
/PRNewswire/ -- Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of...
Source: prnewswire.com
Pentwater Capital Management LP - Form 8.3
Pentwater Capital Management LP - Form 8.3 - Meggitt plc PR Newswire London, August 30 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON
United States City Of United Kingdom Michael Gladstone Panel Market Surveillance Unit Regulatory Information Service
Source: finanznachrichten.de
Versanis Bio Announces Leadership and Board Appointments as Company Prepares to Initiate Phase 2b Study with Novel Approach to Obesity
/PRNewswire/ -- Versanis Bio ("Versanis"), a clinical-stage company advancing novel therapeutics for cardiometabolic diseases, today announced three...
Source: prnewswire.com
Michael Gladstone Acquires 766,667 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stock
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
United States Piper Sandler Michael Gladstone Northern Trust Corp Day One Biopharmaceuticals Company Profile Get Rating Securities Exchange Commission
Source: etfdailynews.com
Pentwater Capital Management LP - Form 8.3
Pentwater Capital Management LP - Form 8.3 - Biffa Plc PR Newswire London, June 16 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH
United States City Of United Kingdom Michael Gladstone Panel Market Surveillance Unit Regulatory Information Service
Source: finanznachrichten.de